Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer

Clinical trial NCT01317641 · COMPLETED

Trial details

NCT number: NCT01317641
Sponsor: Orion Corporation, Orion Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2011-03-01
Primary completion: 2013-07-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.